No Data
No Data
Colgate (CL) Benefits From Strong Pricing & Other Efforts
Household Products Stocks Q4 Results: Benchmarking Colgate-Palmolive (NYSE:CL)
HHS Says In 2025, All People With Medicare Part D Will Benefit From A $2,000 Cap On Annual Out-Of-Pocket Prescription Drug Costs
HHS Says In 2025, All People With Medicare Part D Will Benefit From A $2,000 Cap On Annual Out-Of-Pocket Prescription Drug Costs
Colgate Wants Everyone to Know Your Smile Is Your Superpower With New Campaign
Actress and mom Uzo Aduba partners with Colgate to encourage everyone to smile with confidence NEW YORK, March 25, 2024 /PRNewswire/ -- Colgate believes in celebrating differences—in people and their
With 83% Ownership of the Shares, Colgate-Palmolive Company (NYSE:CL) Is Heavily Dominated by Institutional Owners
Key Insights Institutions' substantial holdings in Colgate-Palmolive implies that they have significant influence over the company's share price 50% of the business is held by the top 25 shareholder
Research Alert: CFRA Lifts View To Buy From Hold On Shares Of Colgate-palmolive Company
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $95, up $9,
No Data